Normal human CD14+ monocytes (Lonza) were cultured in α-MEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, and 20 ng/ml M-CSF for 6 d to expand the precursor population and differentiate into macrophages. Cells were then detached with Accutase (A1110501; Gibco), seeded on tissue-culture plastic dishes, and cultured with M-CSF (20 ng/ml) and RANKL (20 ng/ml) for 9 d to induce multinuclear osteoclast formation, or reseeded on bone slices for bone resorption assay (Raynaud-Messina et al., 2018 (link); Zhu et al., 2020 (link)). Human osteoclasts were cultured with isotype control IgG, MMP9 function-blocking monoclonal antibody (sc-12759L; Santa Cruz), and a function-blocking antibody anti-MMP14 (DX-2400) at 100 μg/ml (Ager et al., 2015 (link); Marshall et al., 2015 (link); Zhu et al., 2020 (link)), in the presence or absence of an anti–GALECTIN-3 blocking antibody (sc-32790L; Santa Cruz) or an anti-LRP1 blocking antibody (MA1-27198; Thermo Fisher Scientific) at 25 μg/ml (Chen et al., 2015 (link); Moxon et al., 2015 (link); Seguin et al., 2017 (link)). DX-2400 was provided by the Kadmon Corporation.